Press Releases

AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Speech balloons

Physicians must tell their own story—for patients’ sake

| 3 Min Read
Profiles positioned as data points across a map of the U.S.

What tops the state advocacy agenda for doctors in 2026

| 7 Min Read
Supportive group holding hands

Time for decisive action on substance-use disorder treatment

| 5 Min Read
Sitting health care worker in a busy hallway

1 in 3 NPs and PAs switch specialties at least once in career

| 6 Min Read